How a specific protein affects dental stem cells and tooth growth
Chromatin modifier Polycomb Repressive Complex 2 as a regulator of dental epithelial progenitor cells
This study is looking at how a specific protein helps control the growth and development of cells that are important for making and repairing teeth, which could lead to new treatments for dental problems.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10883610 on NIH RePORTER |
What this research studies
This research investigates the role of Polycomb Repressive Complex 2 (PRC2) in regulating dental epithelial progenitor cells, which are crucial for tooth development and regeneration. By studying how this complex influences the fate of these cells, the research aims to uncover mechanisms that dictate whether these cells become enamel-producing cells or undergo self-renewal. The approach involves examining the effects of manipulating a key protein, EZH2, on cell behavior during normal conditions and after injury. This could provide insights into potential therapies for dental issues and improve our understanding of stem cell biology in teeth.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals under 21 years old who may have dental issues or are interested in advancements in dental regenerative therapies.
Not a fit: Patients over 21 years old or those without dental health concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for dental conditions by harnessing the regenerative capabilities of dental stem cells.
How similar studies have performed: Other research has shown promising results in understanding stem cell regulation in various tissues, suggesting that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sung, David — University of California, San Francisco
- Study coordinator: Sung, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.